Drug
Ekmasonid
Ekmasonid: highest development phase Phase 1, developed by Hikma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hikma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ekmasonid NCT04854538 | Phase 1 | Healthy |
Latest
No recent events.
Follow Ekmasonid on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.